ABT Abbott Laboratories - Fundamental Analysis
NEUTRAL
Sign in to save
Save this symbol to a watchlist or track a position.
ABT Stock | Fundamental Analysis & Investment Insights
NYSE
Healthcare
Medical Devices
Current Price
Live
$107.42
Analyst Target
$136.67
+27.2%
Upside
52W High
$141.23
52W Low
$105.78
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
72%
Analysis Accuracy
Abbott Laboratories has a weak Piotroski F-Score of 4/9, indicating marginal financial health, and lacks an Altman Z-Score for distress risk assessment. While profitability metrics like gross margin and ROE are solid, earnings growth has collapsed YoY (-80.80%), offsetting strong historical earnings surprises. The stock trades at a significant premium to the Graham Number ($49.26) and intrinsic value ($25.76), though forward P/E of 17.24 suggests improvement. Analysts recommend a buy, but insider selling and weak technicals temper near-term optimism.
Key Strengths
Strong gross margin of 56.42% indicates pricing power and efficient production
Low debt/equity ratio of 0.25 reflects conservative capital structure
Consistent earnings beat history: 3 out of last 4 quarters exceeded estimates
Attractive dividend yield of 2.32% with a sustainable payout ratio of 63.44%
Forward P/E of 17.24 is below current P/E of 29.19, pricing in recovery
Key Risks
Piotroski F-Score of 4/9 signals weak financial stability and operational momentum
YoY earnings growth down sharply by 80.80%, raising concerns about near-term profitability
Insider selling activity: $0.95M in sales over last 6 months with no buys
Stock trades at a steep premium to defensive fair value (Graham Number: $49.26 vs price: $107.42)
Technical trend score of 0/100 indicates strong bearish momentum
AI Fair Value Estimate
Based on comprehensive analysis
$49.26
-54.1% below current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare ABT against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning ABT from our newsroom.
Newest → oldest
No matching news yet.